1. Michelson Diagnostics

    0 Comments Leave a Comment

    1-15 of 207 1 2 3 4 ... 12 13 14 »
    1. Mentioned In 207 Articles

    2. VivoSightOCT Education Centre

      VivoSightOCT Education Centre

      Welcome to the VivoSight OCT Education Centre website This is an open access facility providing information about the use of Optical Coherence Tomography in Dermatology. Please feel free to browse using the navigation guides, We hope you will find the site useful. If you would like to contribute images or just give us some feedback please contact us on info@vivosightatlas.com

      Read Full Article
    3. Michelson Diagnostics closes £2.5 million First Tranche of £4.0 million Series B fundraising Smith & Nephew as Cornerstone Investor

      Michelson Diagnostics closes £2.5 million First Tranche of £4.0 million Series B fundraising Smith & Nephew as Cornerstone Investor
      ...he United States, 2006," 20100316 DCOM- 20100413. About the VivoSight OCT System and Michelson Diagnostics Michelson Diagnostics develops, manufactures and markets the VivoSight multi-beam Optical Coherence Tomography...
      Read Full Article
    4. Processing Optical Coherence Tomography Scans Of A Subject'S Skin

      Processing Optical Coherence Tomography Scans Of A Subject'S Skin

      A method of processing optical coherence tomography (OCT) scans of a subject's skin (7), the skin (7) having a surface(8), the method comprising capturing a plurality of scans through the subject's skin(7), the scans representing an OCT signal in slices through the user's skin (7) in parallel planes, the scans being offset from one another along a direction perpendicular to the parallel planes, the method comprising determining the position of the surface (8) of the skin (7) in each scan and displaying the scans to a user with an indication (9) indicative of a predetermined ...

      Read Full Article
    5. Michelson Diagnostics launches new improved version of VivoSight OCT scanner with Micro-Camera to aid skin cancer diagnosis

      Michelson Diagnostics launches new improved version of VivoSight OCT scanner with Micro-Camera to aid skin cancer diagnosis
      ... EADV on Thursday 9 th October, Room E106, 17:00 18.30. About Michelson Diagnostics and the VivoSight System Michelson Diagnostics has developed a world-leading, patented, medical imaging technology, known as multi-beam...
      Read Full Article
    6. Optical coherence tomography imaging of erythematotelangiectatic rosacea during treatment with brimonidine topical gel 0.33%: a potential method for treatment outcome assessment

      Optical coherence tomography imaging of erythematotelangiectatic rosacea during treatment with brimonidine topical gel 0.33%: a potential method for treatment outcome assessment

      BACKGROUND: Patients with moderate to severe rosacea often seek treatment to reduce erythema and vascular markings. Few studies have looked at the effectiveness of the novel treatment, brimonidine topical gel 0.33%, trademark name Mirvaso®, in the treatment of rosacea. We report the use of optical coherence tomography (OCT) scanning to monitor the effectiveness of Mirvaso® on in vivo skin. OCT is a non-invasive optical imaging technique that can provide high-resolution imaging of vessel and cellular morphology. OCT may be useful as a pre-treatment assessment tool for identifying possible morphologic features in the skin that may serve as outcome predictors ...

      Read Full Article
    7. Feature Of The Week 6/8/14: Automated Registration of OCT and Dermoscopy in the Assessment in Basal Cell Carcinoma

      Feature Of The Week 6/8/14: Automated Registration of OCT and Dermoscopy in the Assessment in Basal Cell Carcinoma

      Optical coherence tomography (OCT) has been shown to be of clinical value in imaging basal cell carcinoma (BCC). A novel dual OCT-video imaging system, providing automated registration of OCT and dermoscopy, has been developed to assess the potential of OCT in measuring the degree of sub-clinical spread of BCC. Seventeen patients selected for Mohs micrographic surgery (MMS) for BCC were recruited to the study. The extent of BCC infiltration beyond a segment of the clinically assessed pre-surgical border was evaluated using OCT. Sufficiently accurate (<0.5 mm) registration of OCT and dermoscopy images was achieved in 9 patients. The location ...

      Read Full Article
    8. 1-15 of 207 1 2 3 4 ... 12 13 14 »
  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. About Michelson Diagnostics

    Michelson Diagnostics

    Michelson Diagnostics.  Microscopy Systems.  Michelson Diagnostics Ltd (MDL) is a healthcare company providing a live view of cancerous tissue.  The company was formed in March 2006 to develop a hand-held cancer scanner based on an imaging technology called optical coherence tomography (OCT).   The patented device will give clinicians and researchers a live view of sub-surface tissue structures at near-cellular resolution - high enough to see the emergence and growth of cancer. It shows tissue as deep as 2 mm and offers much higher image resolution than ultrasound or MRI.  The non-invasive cancer scan reduces the need for painful and costly biopsies and provides patients and doctors with immediate results. Whole organs can be systematically scanned for abnormalities.

  3. Quotes about Michelson Diagnostics

    1. I found the MedTech Tour Summit extremely useful: the high standard of presenting companies at different stages of their business development provided insights into how I need to position Michelson Diagnostics for an investment. I also made contact with several interested investors and advisors, and discussions are progressing.
      Jon Holmes in Michelson Diagnostics is Singled Out for Growth
    2. Michelson Diagnostics has applied their outstanding technology to forward thinking products and I am extremely pleased to be representing the company in the US.
      Kevin C. Oakley in Michelson Diagnostics Opens US Offices And Appoints US Business Development Manager
    3. This is a remarkable milestone for Michelson Diagnostics, as it shows, through a statistically significant sample, that multi-beam OCT technology has the potential to play an important role in the early diagnosis of cancer.
      Jon Holmes in Michelson Diagnostics Reports First Quantitative Results on Cancer Diagnosis Using Multi-beam OCT imaging